Location History:
- Bad Krozingen, DE (1999)
- Weil am Rhein, DE (2002)
Company Filing History:
Years Active: 1999-2002
Title: Rainer Alex: Innovator in Pharmaceutical Technology
Introduction
Rainer Alex is a notable inventor based in Weil am Rhein, Germany. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative encapsulation processes and injection devices. With a total of 2 patents, his work has the potential to enhance the efficacy and safety of drug delivery systems.
Latest Patents
Rainer Alex's latest patents include a process for encapsulating shear sensitive fill masses into capsules and a dermally affixed injection device. The encapsulation process involves heating and cooling the shear sensitive fill mass, which contains a pharmaceutical active agent or nutrient, prior to encapsulation. This method results in capsules that exhibit a high and constant dissolution rate. The dermally affixed injection device features a casing with an active substance reservoir, a cannula for injection, and a protective element that ensures safe usage. This innovative design improves the reliability and effectiveness of drug administration.
Career Highlights
Rainer Alex is currently employed at Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at the company has allowed him to focus on developing advanced technologies that address critical challenges in drug delivery. His inventions reflect a commitment to improving patient outcomes through innovative solutions.
Collaborations
Rainer has collaborated with esteemed colleagues such as Paul Hadvary and Hansjorg Tschirky. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their innovations.
Conclusion
Rainer Alex's contributions to pharmaceutical technology through his patents and collaborative efforts highlight his role as a key innovator in the field. His work continues to pave the way for advancements in drug delivery systems, ultimately benefiting patients worldwide.